English
Język Polski
NOVEL TRENDS IN ANTIPSYCHOTIC DRUG DEVELOPMENT
Grzegorz Ślifirski
Tomasz Słowiński
Jacek Stefanowicz
Abstract
Schizophrenia is a severe, chronic mental illness that affects approximately 1% of the population. It is associated with a shortened lifespan and significant impairments in social and vocational functioning. Multiple domains of symptoms, e.g. positive and negative symptoms as well as cognitive deficits demand a complex approach to treatment. Results of recent large-scale studies comparing the effectiveness of typical versus atypical antipsychotics appear to indicate that second generation agents are neither more effective, nor associated with better cognitive or social outcomes. The rational development of intentionally designed multi-target agents may solve these therapeutic problems, resulting in the next generation of CNS drugs.
Keywords:
atypical antipsychotic drugs, antipsychotics, schizophrenia, single-target agents, multi-target agentsSimilar Articles
- Mateusz Żaczko, Tomasz Lorenc, Wioletta Olejarz, Grażyna Nowicka, PERSPECTIVES OF THERAPEUTIC USE OF EXOSOMES IN THE MOST COMMON CANCERS , Prospects in Pharmaceutical Sciences: Vol. 17 No. 6 (2019)
- Helena E. Makulska-Nowak, ALCOHOL VERSUS CANNABIS - COMPARISON OF RISK , Prospects in Pharmaceutical Sciences: Vol. 11 No. 6 (2013)
- Maciej Bara, Jakub Starownik, Jakub Szydło, Patryk Gryszkiewicz, Jakub Nieznański, Dapagliflozin - new solution in chronic kidney disease treatment , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
- Maria Rybicka, Anna Seroka, Michał Obrębski, Justyna Chwiejczak, Aleksander Górny, Jan Kościan, Julita Młynarska, Karolina Szczerkowska, Anna Wójcik, Maria Mitkowska, Lipoprotein(a) - gaining clinical importance as a cardiovascular risk factor. Current state of medical knowledge. , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Anna Dominiczak, Agata Janczak, Martyna Wołek, Katarzyna Mazurek, Maciej Bara, Proton pump inhibitors: prolonged intake and adverse effects , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
- Mustafa Sevindik, Celal Bal, Emre Cem Eraslan, İmran Uysal, Falah Saleh Mohammed, Medicinal mushrooms: a comprehensive study on their antiviral potential , Prospects in Pharmaceutical Sciences: Vol. 21 No. 2 (2023)
- Paulina Dąbrowska, Michał Żuber, Michał Dacka, Efficacy and safety of bempedoic acid in lipid disorder therapy: a review of clinical trials , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka, SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
- Agnieszka Sokal, Edyta Pindelska, COCRYSTALS - A NEW DRUG FORM , Prospects in Pharmaceutical Sciences: Vol. 11 No. 5 (2013)
- Grzegorz Nałęcz-Jawecki, WATER ENVIROMENT TOXICITY INVESTIGATED BY BIOASSAYS , Prospects in Pharmaceutical Sciences: Vol. 1 No. 2 (2003)
You may also start an advanced similarity search for this article.
Details
References
Statistics
Authors
Citation rules
Cited by / Share
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.